Ambulatory surgery centers (ASCs) continue to play a central role in the shift toward outpatient care—and with this shift come new opportunities, complex decisions, and heightened interest from private equity firms, hospitals, and independent medical groups. In our recent webinar, Blueprint to Buyout: A Strategic Guide to ASC Success, Mark Reiboldt moderated a panel discussion with Andrew Hranka, Richard Romero, and Wendy Bruno Thomson, exploring market forces, valuation drivers, and practical steps for building, optimizing, or preparing to sell an ASC.
The conversation centered on the growing demand for ASC services and the realities needed to support long-term success—whether developing a new center, restructuring an existing one, or weighing a potential partnership or transaction.
Wendy Bruno Thomson opened by highlighting sustained growth in the ASC market, with more than 10,000 ASCs nationwide and continued payer support for shifting surgeries out of the hospital setting. But growth does not guarantee profitability. Many ASCs are struggling due to operational inefficiencies, shifting ownership dynamics, or a lack of strategic planning.
Key themes included:
ASCs remain a powerful engine for physician productivity and financial performance—if they are built and managed with intention.
Much of the webinar focused on the importance of long-range planning from day one. Owners often default to short-term thinking—such as quick revenue wins or basic operational setup—but overlooking structure, governance, and exit pathways can derail future opportunities.
Key planning considerations:
Groups must design today’s ASC with tomorrow’s goals in mind.
Andrew Hranka discussed the private equity perspective, noting that PE activity in ASCs continues to rise because ASCs:
PE sponsors typically evaluate:
Private equity wants stability, scalability, and a clear pathway to expansion—not just strong current-state financials.
Richard Romero emphasized that ASC valuation is fundamentally the story of benefit versus risk, shaped primarily by:
Most overlooked valuation drag? Capacity constraints. OR availability, staffing shortages, and operational bottlenecks often undermine otherwise strong financial performance.
Other valuation must-haves:
A valuation without a clear operating story creates uncertainty—and uncertainty suppresses value.
The most successful ASC transactions begin 12–18 months before going to market.
Preparation steps include:
These steps not only improve performance but also increase future deal value.
Whether launching a new ASC, expanding capacity, or preparing for a sale, today’s leaders must think beyond daily operations and plan for the long-term vision that determines lasting success.